Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of ATS907 in Primary Open Angle Glaucoma and Ocular Hypertension
NCT01668524Phase 2Completed
- Sponsor
- Altheos, Inc.
- Start
- Aug 2012
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ATS-907 in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Altheos, Inc.. Started Aug 2012; status: completed.
02
Drugs
ATS-907
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01668524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01668524.